Press center

Roquette today celebrates the grand opening of its new Pharmaceutical Innovation Center, located near Philadelphia, Pennsylvania, right in the heart of the United States’ Northeastern pharmaceutical corridor.

Discover the latest innovations in direct compression technology, designed to overcome unique drug formulation challenges and support expansion into novel application areas.

Following its purchase of a majority share in the company in 2018, this latest move allows Roquette to continue realizing its strong growth ambitions and meet rising global demand for high-quality plant-based excipients.

Developed specifically for active pharmaceutical ingredients (APIs) that are highly sensitive to reducing sugars, PEARLITOL® 150 SD supports opportunities to unlock advanced tablet dosage forms – even when using challenging active ingredients.

Roquette invests €25 million at its site in Lestrem, France, to strengthen its unique position in the polyols market.